4-肼基-2-(甲基巯基)嘧啶 | 104408-29-9

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 中文名称: 4-肼基-2-(甲基巯基)嘧啶
• 英文名称: 4-hydrazineyl-2-(methylthio)pyrimidine
• 英文别名: 4-hydrazino-2-(methylthio)pyrimidine；4-hydrazinyl-2-(methylthio)pyrimidine；N-(2-methylsulfanyl-pyrimidin-4-yl)-hydrazine；4-Hydrazino-2-(methylsulfanyl)pyrimidine；(2-methylsulfanylpyrimidin-4-yl)hydrazine
• CAS: 104408-29-9
• 化学式: C₅H₈N₄S
• mdl: MFCD01223746
• 分子量: 156.211
• InChiKey: AHMAKFIBYJTQAW-UHFFFAOYSA-N

物化性质

• 熔点：
  143-145°
• 沸点：
  303.6±25.0 °C(Predicted)
• 密度：
  1.43±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  10
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  89.1
• 氢给体数：
  2
• 氢受体数：
  5

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2933990090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

反应信息

• 作为反应物：
  描述：

  4-肼基-2-(甲基巯基)嘧啶 在 bis(tri-tert-butylphosphine)palladium(0) 、 sodium hydroxide 、 sodium t-butanolate 作用下， 以 1,4-二氧六环 、 乙醇 为溶剂， 生成 4-(4-methanesulfonyl-piperidin-1-yl)-1-(2-methylsulfanyl-pyrimidin-4-yl)-1H-indazole
  参考文献：
  名称：

  Development of indole/indazole-aminopyrimidines as inhibitors of c-Jun N-terminal kinase (JNK): Optimization for JNK potency and physicochemical properties

  摘要：

  A novel series of indole/indazole-aminopyrimidines was designed and synthesized with an aim to achieve optimal potency and selectivity for the c-Jun kinase family or JNKs. Structure guided design was used to optimize the series resulting in a significant potency improvement. The best compound (17) has IC50 of 3 nM for JNK1 and 20 nM for JNK2, with greater than 40-fold selectivity against other kinases with good physicochemical and pharmacokinetic properties. (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2013.04.029
• 作为产物：
  描述：

  2-甲硫基-4-氯嘧啶 在 肼 作用下， 以 乙醇 为溶剂， 反应 16.0h， 生成 4-肼基-2-(甲基巯基)嘧啶
  参考文献：
  名称：

  Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase

  摘要：

  本发明提供了物质组合物、试剂盒和它们在治疗MAP激酶相关疾病和/或HMG-CoA还原酶相关疾病中的应用的方法。具体而言，本发明提供了用于通过抑制p38α MAP激酶和/或HMG-CoA还原酶来治疗动物主体的炎症和/或心血管疾病的组合物，以及提供这些组合物的配方和给药方式。本发明还提供了用于有理设计MAP激酶、HMG-CoA还原酶或两者的抑制剂的方法，用于实施本发明。

  公开号：

  US20050261354A1

文献信息

• 단백질 인산화 효소 저해 활성을 갖는 신규한 피라졸 유도체 및 이의 용도
  申请人：Industry-University Cooperation Foundation Hanyang University ERICA Campus 한양대학교 에리카산학협력단(120120008551) Corp. No ▼ 131471-0017977BRN ▼134-82-10205

  公开号：KR20210069576A

  公开（公告）日：2021-06-11

  본 발명은 신규 피라졸 유도체 화합물, 이의 이성질체 또는 이의 약학적으로 허용 가능한 염 및 이를 포함하는 약학적 조성물에 관한 것이다. 본 발명에 따른 피라졸 유도체 화합물은 JNK, 특히 JNK3에 대해 선택적으로 저해 활성을 나타내어 신경계 질환 (알츠하이머성 치매성 치매, 파킨슨 질환을 포함하는 퇴행성 뇌질환)의 예방 및 치료용 약학적 조성물로 이용될 수 있다.

  本发明涉及新的吡라졸衍生物化合物，其立体异构体或其药学上可接受的盐以及包含它们的药学组合物。根据本发明，吡라졸衍生物化合物表现出对JNK，特别是JNK3的选择性抑制活性，可用作预防和治疗神经系统疾病（包括阿尔茨海默病、帕金森病等退行性脑疾病）的药学组合物。
• Inhibitors of JNK
  申请人：Gong Leyi

  公开号：US20110034470A1

  公开（公告）日：2011-02-10

  The invention relates to JNK inhibitors and corresponding methods, formulations, and compositions for inhibiting JNK and treating JNK-mediated disorders. The application discloses JNK inhibitors, as described below in Formula I: wherein p, q, Y′, r, R 1 , R 2 , X, X 1 , X 2 , X 3 , and X 4 are as defined herein. The compounds and compositions disclosed herein are useful to modulate the activity of JNK and treat diseases associated with JNK activity. Disclosed are methods and formulations for inhibiting JNK and treating JNK-mediated disorders, and the like, with the compounds, and processes for making said compounds, and corresponding compositions, disclosed herein.

  该发明涉及JNK抑制剂及相应的用于抑制JNK和治疗JNK介导的疾病的方法、配方和组合物。该申请披露了如下所述的JNK抑制剂，其化学式如下： 其中p、q、Y'、r、R1、R2、X、X1、X2、X3和X4如本文所定义。本文披露的化合物和组合物可用于调节JNK的活性并治疗与JNK活性相关的疾病。本文还披露了用于抑制JNK和治疗JNK介导的疾病等的方法和配方，以及用于制备上述化合物的过程和相应的组合物。
• Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
  申请人：Griffin John

  公开号：US20050261354A1

  公开（公告）日：2005-11-24

  The present invention provides compositions of matter, kits and methods for their use in the treatment of MAP kinase-related conditions and/or HMG-CoA reductase-related conditions. In particular, the invention provides compositions for treating inflammatory and/or cardiovascular conditions in an animal subject by inhibiting p38α MAP kinase and/or HMG-CoA reductase, as well as providing formulations and modes of administering such compositions. The invention further provides methods for the rational design of inhibitors of MAP kinase, HMG-CoA reductase, or both for use in the practice of the present invention.

  本发明提供了物质组合物、试剂盒和它们在治疗MAP激酶相关疾病和/或HMG-CoA还原酶相关疾病中的应用的方法。具体而言，本发明提供了用于通过抑制p38α MAP激酶和/或HMG-CoA还原酶来治疗动物主体的炎症和/或心血管疾病的组合物，以及提供这些组合物的配方和给药方式。本发明还提供了用于有理设计MAP激酶、HMG-CoA还原酶或两者的抑制剂的方法，用于实施本发明。
• Synthesis of fused 3-amino-1,2,4-triazoles via sequential addition of aryl hydrazines to isothiocyanates and I 2 -mediated cyclodesulfurization
  作者：Shufeng Jiao、Zhen Wang、Qiongli Zhao、Wenquan Yu、Junbiao Chang

  DOI：10.1016/j.tet.2018.05.009

  日期：2018.6

  A variety of fused 3-amino-1,2,4-triazole derivatives were synthesized via addition of aryl hydrazines to isothiocyanates followed by I2-mediated oxidative cyclodesulfurization. This transition-metal-free synthetic process provides facile access to 1,2,4-triazolo[4,3-a]pyridines and related heterocyclic frameworks bearing a 3-amino substituent from readily accessible substrates in an efficient and

  通过将芳基肼加到异硫氰酸酯中，然后进行I 2介导的氧化环脱硫，合成了多种稠合的3-氨基-1,2,4-三唑衍生物。这种无过渡金属的合成方法可轻松，高效地从容易获得的底物中轻松获得1,2,4-三唑并[4,3- a ]吡啶和带有3-氨基取代基的相关杂环骨架。
• Synthesis of 1,2,4-Triazolo[4,3-<i>a</i> ]pyridines and Related Heterocycles by Sequential Condensation and Iodine-Mediated Oxidative Cyclization
  作者：Ertong Li、Zhiyuan Hu、Lina Song、Wenquan Yu、Junbiao Chang

  DOI：10.1002/chem.201601744

  日期：2016.7.25

  A facile and efficient approach to access 1,2,4‐triazolo[4,3‐a]pyridines and related heterocycles has been accomplished through condensation of readily available aryl hydrazines with corresponding aldehydes followed by iodine‐mediated oxidative cyclization. This transition‐metal‐free synthetic process is broadly applicable to a variety of aromatic, aliphatic, and α,β‐unsaturated aldehydes, and can

  通过容易获得的芳基肼与相应的醛缩合，然后由碘介导的氧化环化反应，可以轻松而有效地获得1,2,4-三唑并[4,3- a ]吡啶和相关杂环。这种无过渡金属的合成方法广泛适用于各种芳香族，脂肪族和α，β-不饱和醛类，并且可以以克为单位方便地进行。